The Vasoreparative Function of Myeloid Angiogenic Cells Is Impaired in Diabetes Through the Induction of IL1β

Myeloid angiogenic cells (MACs) promote revascularization through the paracrine release of angiogenic factors and have been harnessed as therapeutic cells for many ischemic diseases. However, their proangiogenic properties have been suggested to be diminished in diabetes. This study investigates how...

Descripción completa

Detalles Bibliográficos
Autores principales: Chambers, Sarah E. J., O'Neill, Christina L., Guduric‐Fuchs, Jasenka, McLoughlin, Kiran J., Liew, Aaron, Egan, Aoife M., O'Brien, Timothy, Stitt, Alan W., Medina, Reinhold J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Regenerative Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001623/
https://www.ncbi.nlm.nih.gov/pubmed/29484768
http://dx.doi.org/10.1002/stem.2810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001623/
https://www.ncbi.nlm.nih.gov/pubmed/29484768
http://dx.doi.org/10.1002/stem.2810

Ejemplares similares